The beginning of a new earnings season adds another potential source of volatility to the markets. While Israel-Iran escalation is a key theme in the markets now and will likely remain so in the coming days as we await Israel's response to the latest Iranian airstrikes. Nevertheless, earnings reports will likely influence moves on the individual stocks.
While Wall Street earnings calendar for this week remains dominated by financial companies, traders will also get some interesting reports from other sectors. Reports from Netflix (NFLX.US) and TSMC (TSM.US) are perfect examples. Among this week's releases, one can also find reports from 6 Dow Jones members:
- American Express (AXP.US)
- Goldman Sachs (GS.US)
- Johnson & Johnson (JNJ.US)
- UnitedHealth Group (UNH.US)
- Travelers (TRV.US)
- Procter & Gamble (PG.US)
Top Wall Street earnings report scheduled for this week. Source: Bloomberg Finance LP, XTB Research
Apple earnings beat Wall Street estimates 🚨 iPhone sales below expectations
🗽S&P 500 companies with the record net margin since 2009 - FactSet data
Market Wrap: UK100 skyrockets after BoE 🇬🇧 🚀 Euphoric gain as ECB Lagarde speaks 🇪🇺 📈
Apple Q2 2026: stable results or the beginning of a new growth cycle?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
